Literature DB >> 6582272

A World Health Organization perspective.

V Grabauskas.   

Abstract

Mesh：

Year:  1983        PMID： 6582272

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN： 0380-0903


× No keyword cloud information.
  6 in total

1.  Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology.

Authors:  Uhunmwangho U Courage; Dungwom P Stephen; Imoh C Lucius; Charles Ani; Agbaji O Oche; Agaba I Emmanuel; Adelowo O Olufemi
Journal:  Clin Rheumatol       Date:  2017-04-26       Impact factor: 2.980

2.  Epidemiology of rheumatic diseases in rural and urban populations in Indonesia: a World Health Organisation International League Against Rheumatism COPCORD study, stage I, phase 2.

Authors:  J Darmawan; H A Valkenburg; K D Muirden; R D Wigley
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 3.  The WHO-ILAR COPCORD Bhigwan (India) model: foundation for a future COPCORD design and data repository.

Authors:  Arvind Chopra
Journal:  Clin Rheumatol       Date:  2006-04-13       Impact factor: 2.980

4.  Arthritis community education by leather puppet (wayang kulit) shadow play in rural Indonesia (Java).

Authors:  J Darmawan; K D Muirden; R D Wigley; H A Valkenburg
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

5.  Incidence of musculoskeletal pain in adult Kuwaitis using the validated Arabic version of the WHO-ILAR COPCORD Core Questionnaire.

Authors:  Adel M Al-Awadhi; Samuel O Olusi; Khaled Al-Saeid; Mohamed Moussa; Dia Shehab; Naji Al-Zaid; Adeeba Al-Herz; Khalid Al-Jarallah
Journal:  Ann Saudi Med       Date:  2005 Nov-Dec       Impact factor: 1.526

Review 6.  Recommendations from the Community Oriented Program for Control of Rheumatic Disease for data collection for the measurement and monitoring of health in developing countries.

Authors:  John Darmawan
Journal:  Clin Rheumatol       Date:  2007-03-16       Impact factor: 3.650
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.